This content is machine translated Chronic inflammatory skin diseases Positive long-term effects in moderate to severe psoriasis Recently published data from the multicenter LIBERATE study confirm the favorable benefit-risk profile of apremilast with long-term use. This is a significant advance for the treatment options of this patient…
View Post 1 min This content is machine translated Migraine prevention Peptide receptor blockade also effective and safe in the long term It is estimated that about 11% of the population suffers from migraine. Effective therapeutic options, especially for prophylaxis, are therefore urgently needed. Study results now also confirm long-term efficacy for…
View Post 5 min This content is machine translated Irritable Bowel Syndrome Nutrition as an important pillar in treatment Irritable bowel patients suffer from intolerance reactions to food. A low-FODMAP diet or a gluten-free diet can significantly alleviate these symptoms.
View Post 3 min This content is machine translated Migraine prophylaxis Expanded treatment options with CGRP antibodies Migraine is the most common neurological disorder and severely affects the quality of life of those affected. To prevent chronicity, prophylactic measures are becoming increasingly important in migraine therapy. The…
View Post 2 min This content is machine translated Migraine therapy Promising non-drug acute treatment via neurostimulation. External stimulation of the trigeminal nerve has already proven effective in migraine prevention. The great advantage is the drug-free treatment, due to which there are practically no side effects. Recent…
View Post 2 min This content is machine translated Giant cell arteritis Indication expansion of Actemra® in Switzerland Until now, only high-dose steroids have been available for the potentially life-threatening autoimmune disease giant gall arteritis. This has changed with the first commercially available non-steroidal biotherapeutic targeting the IL-6…
View Post 3 min This content is machine translated RMS and PPMS Early therapy with ocrelizumab slows the disease More than 100,000 people with MS are being treated with ocrelizumab worldwide. New analysis shows that drug exposure and low B-cell levels reduce the risk of progression. Long-term data advise…
View Post 2 min This content is machine translated "Crystalline Sponge" technology Merck & Rigaku: Pioneering innovation project launched The goal of the strategic partnership is to make the complex “Crystalline Sponge” technology available to laboratories in the chemical and life science industries for the analysis of molecular structures…
View Post 3 min This content is machine translated Dangers of multimedication Pay attention to interactions According to the WHO definition, more than 5 drugs per day is considered polypharmacotherapy and is especially common in elderly patients. In the over-70 age group, up to half of…
View Post 2 min This content is machine translated Type 2 diabetes Less hypoglycemia with insulin glargine 300 E/ml The altered pharmacokinetics and dynamics of the drug are associated with a reduced risk of hypoglycemia.
View Post 7 min This content is machine translated ICS in asthma and COPD - therapy over time De-escalate for a change COPD is associated with high morbidity and mortality. It is currently the fourth leading cause of death worldwide, and according to a prediction by the Global Burden of Disease Study,…
